Telix Pharmaceuticals (TLPPF) News Today $16.53 +0.50 (+3.14%) As of 06/2/2025 10:56 AM Eastern Add Compare Share Share Headlines Stock AnalysisChartFinancialsHeadlinesSEC FilingsShort InterestBuy This Stock TLPPF Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period Telix Pharmaceuticals Expands Global Product ApprovalsMay 20, 2025 | tipranks.comTelix Pharmaceuticals to Release Shares from Voluntary EscrowMay 18, 2025 | tipranks.comTelix Pharmaceuticals Expands Market Presence with New Securities QuotationMay 16, 2025 | tipranks.comIs Telix Pharmaceuticals Limited (TLX) the Best Australian Stock to Buy According to Analysts?May 15, 2025 | msn.comTelix Pharmeceuticals: Imaging Biomarkers Paving The Way For TheranosticsMay 13, 2025 | seekingalpha.comTelix Pharmaceuticals Issues Unquoted Share Rights to EmployeesMay 8, 2025 | tipranks.comTelix Pharmaceuticals Expands ASX Quotation with New SecuritiesMay 5, 2025 | tipranks.comAnalysts Offer Insights on Healthcare Companies: Telix Pharmaceuticals (OtherTLPPF) and Alnylam Pharma (ALNY)April 30, 2025 | theglobeandmail.comUBS Keeps Their Buy Rating on Telix Pharmaceuticals (TLPPF)April 30, 2025 | theglobeandmail.comTelix Pharmaceuticals Ltd. (TLPPF) Receives a Buy from UBSApril 24, 2025 | markets.businessinsider.comBell Potter Remains a Buy on Telix Pharmaceuticals Ltd. (TLPPF)April 24, 2025 | markets.businessinsider.comTelix Pharmaceuticals to Release Shares from Voluntary EscrowApril 23, 2025 | tipranks.comTelix Pharmaceuticals Reports Promising Results for TLX101 Glioma TherapyApril 15, 2025 | tipranks.comUBS Remains a Buy on Telix Pharmaceuticals Ltd. (TLPPF)April 8, 2025 | markets.businessinsider.comTelix Pharmaceuticals gets new technology chiefApril 7, 2025 | msn.comTelix Pharmaceuticals Unaffected by U.S. Trade Tariffs and Chinese Export ControlsApril 7, 2025 | tipranks.comTelix Pharmaceuticals: Building A Radiopharma PowerhouseApril 5, 2025 | seekingalpha.comTelix Pharmaceuticals to Release Shares from Voluntary EscrowApril 2, 2025 | tipranks.comTelix Pharmaceuticals to Release Shares from Voluntary EscrowApril 2, 2025 | tipranks.comTelix Pharmaceuticals to Release Shares from Voluntary EscrowApril 1, 2025 | tipranks.comWilsons Sticks to Its Buy Rating for Telix Pharmaceuticals Ltd. (TLPPF)March 25, 2025 | markets.businessinsider.comTelix Pharmaceuticals' New Drug Application for Prostate Imaging Drug Gets FDA ApprovalMarch 21, 2025 | marketwatch.comTLX Telix Pharmaceuticals LimitedMarch 14, 2025 | seekingalpha.comTelix’s new lead-212 generator could dispel medical isotope scalability hurdlesMarch 14, 2025 | msn.comTelix Pharmaceuticals Expands Theranostic Pipeline with FAP-targeting AcquisitionMarch 11, 2025 | tipranks.comTelix kidney cancer imaging agent granted FDA priority reviewFebruary 26, 2025 | msn.comFDA Accepts Telix’s Kidney Cancer Imaging Agent for Priority ReviewFebruary 25, 2025 | tipranks.comTelix Pharmaceuticals Announces Board Renewal and Leadership ChangesFebruary 25, 2025 | msn.comWilsons Sticks to Their Buy Rating for Telix Pharmaceuticals Ltd. (TLPPF)February 25, 2025 | markets.businessinsider.comTelix Pharmaceuticals Shifts Reporting Currency to USDFebruary 24, 2025 | tipranks.comAnalysts’ Opinions Are Mixed on These Healthcare Stocks: Nanosonics Limited (OtherNNCSF) and Telix Pharmaceuticals Ltd. (OtherTLPPF)February 23, 2025 | markets.businessinsider.comAustralia's Telix Pharmaceuticals jumps to record on robust forecast, resultsFebruary 21, 2025 | msn.comTelix Pharmaceuticals Limited (TLPPF) FY 2024 Results Earnings Call TranscriptFebruary 20, 2025 | seekingalpha.comAustralia's Telix Pharmaceuticals scales record peak on upbeat revenue forecastFebruary 20, 2025 | reuters.comIs Telix Pharmaceuticals Limited (TLX) the Best Long Term ASX Stock to Buy Now?February 11, 2025 | insidermonkey.comTelix Pharmaceuticals acquires ImaginAb assets and technologyJanuary 30, 2025 | msn.comTelix Pharmaceuticals Boosts Oncology Capabilities with ImaginAb AcquisitionJanuary 30, 2025 | tipranks.comBuy Rating for Telix Pharmaceuticals Ltd. Supported by Strong Financials and Growth PotentialJanuary 30, 2025 | markets.businessinsider.comJP Morgan 2025: Radiopharmaceuticals M&A fuels Telix’s busy yearJanuary 17, 2025 | msn.comTelix Pharmaceuticals (TLX) Shares Soar on FY24 SuccessJanuary 14, 2025 | tipranks.comTelix Pharmaceuticals Expands Therapeutic Pipeline with Strategic AcquisitionJanuary 12, 2025 | tipranks.comTelix Pharmaceuticals Ltd. (TLPPF) Gets a Buy from UBSDecember 13, 2024 | markets.businessinsider.comTelix Pharmaceuticals Updates Securities Policy Amid Market InterestDecember 12, 2024 | markets.businessinsider.comUBS Sticks to Their Buy Rating for Telix Pharmaceuticals Ltd. (TLPPF)December 9, 2024 | markets.businessinsider.comPlus Therapeutics Announces Renewal Of Master Services Agreement With TelixDecember 4, 2024 | markets.businessinsider.comTelix Pharma doses first patient in Phase III PET carcinoma trialNovember 29, 2024 | msn.comTelix to Add FAP-Targeting Candidates to Theranostic PipelineNovember 18, 2024 | globenewswire.comTelix ADSs Commence Trading on NasdaqNovember 13, 2024 | globenewswire.comTelix plans $125m acquisition of radiopharmaceuticals company QSAMNovember 7, 2024 | msn.comTelix Welcomes CMS Decision to Improve Payments for Diagnostic RadiopharmaceuticalsNovember 3, 2024 | globenewswire.com Get Telix Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for TLPPF and its competitors with MarketBeat's FREE daily newsletter. Email Address TLPPF Media Mentions By Week TLPPF Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TLPPF News Sentiment▼0.000.88▲Average Medical News Sentiment TLPPF News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TLPPF Articles This Week▼01▲TLPPF Articles Average Week Get Telix Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for TLPPF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Algernon Pharmaceuticals News Today ALK-Abelló A/S News Today Alpha Tau Medical News Today Arno Therapeutics News Today Ascentage Pharma Group International News Today Ascletis Pharma News Today Avacta Group News Today Awakn Life Sciences News Today BerGenBio ASA News Today BriaCell Therapeutics News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:TLPPF) was last updated on 6/3/2025 by MarketBeat.com Staff From Our PartnersDo You Believe In President Trump? Answer This 1 QuestionThey said you wouldn’t last—that Bidenflation, Wall Street selloffs, and DEI funds would break your loyalty to...Colonial Metals | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredThe DOJ Just Paved the Way for Account SeizuresWashington is running out of money…And guess where they'll look next? When governments go broke, they take ...Priority Gold | SponsoredThe Social Security Changes No One’s Talking AboutWhile most Americans worry about their next Social Security check... something far bigger is happening behind ...Altimetry | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredThe Real Reason Silver Prices Are SoaringElon Musk is back in the spotlight—this time for fueling a global scramble for silver. Tesla's relentless p...GoldenCrest Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Telix Pharmaceuticals Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Telix Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy TLPPF Stock Free TLPPF Stock Alerts